Gastric Cancer
📧 Sign up to get email alerts when something new happens for Gastric Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-10-19Clinical Trial Update: Effect of CNSI vs. ICG in Lymph Node Tracing During Gastrectomy [Phase 2]
Phase 2 trial update comparing CNSI versus ICG for lymph node tracing during gastrectomy in gastric cancer patients.
-
CLINICAL_TRIALS trial_result · 2023-10-19Clinical Trial Update: Three Drugs in Advanced Gastric Cancer Neoadjuvant Chemotherapy for Stage Ⅲ Clinical Study [Phase 2]
Phase 2 neoadjuvant chemotherapy trial in advanced gastric cancer has completed enrollment.
-
CLINICAL_TRIALS trial_result · 2023-10-13Clinical Trial Update: A Phase I/II Study of MEDI4736 in Combination With Olaparib in Patients With Advanced Solid Tumors. [Phase 1, Phase 2]
A Phase I/II study evaluating atezolizumab in combination with olaparib in patients with advanced solid tumors, including ovarian, breast, s…
-
CLINICAL_TRIALS trial_result · 2023-10-12Clinical Trial Update: Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-859/KEYNOTE-859) [Phase 3]
Phase 3 trial MK-3475-859 (KEYNOTE-859) evaluating pembrolizumab plus chemotherapy versus placebo plus chemotherapy in gastric/GEJ adenocarc…
-
CLINICAL_TRIALS trial_result · 2023-10-10Clinical Trial Update: Randomized Controlled Trial on Effect of Lymph Node Mapping by Indocyanine Green Via Submucosal or Subserosal Injection [Phase 3]
Phase 3 randomized trial evaluating lymph node mapping with indocyanine green injected submucosally or subserosally in gastric cancer patien…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-09-29Clinical Trial Update: Comparison of SEEOX and SOX Regimens in Stage ⅢB/ⅢC Gastric Cancer Patients [Phase 3]
Phase 3 clinical trial comparing SEEOX and SOX regimens in stage IIIb/IIIc gastric cancer; status currently unknown.
-
CLINICAL_TRIALS trial_result · 2023-09-28Clinical Trial Update: Efficacy and Safety of SOX Regimen Combined With Camrelizumab as Neoadjuvant Treatment in Locally Advanced Gastric Cancer: a Phase II, Single-arm Study [Phase 2]
Phase II, single-arm trial evaluating SOX regimen plus camrelizumab as neoadjuvant therapy for locally advanced gastric cancer; study status…
-
CLINICAL_TRIALS trial_result · 2023-09-28Clinical Trial Update: High Dose Vitamin C Combined With Metformin in the Treatment of Malignant Tumors [Phase 2]
Phase 2 trial update evaluating high-dose vitamin C with metformin for malignant tumors including hepatocellular and pancreatic cancer.
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: Study of BGB-290 or Placebo in Participants With Advanced or Inoperable Gastric Cancer [Phase 2]
BeiGene's Phase 2 study of BGB-290 versus placebo in advanced or inoperable gastric cancer has completed, with results posted in September 2…
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: Sintilimab in Combination With S-1/Oxaliplatin With Nab-paclitaxel Intraperitoneal Infusion for Untreated Advanced Gastric Cancer With Malignant Ascites [Phase 2]
Phase 2 trial evaluating sintilimab with S-1/oxaliplatin plus nab-paclitaxel intraperitoneal infusion for untreated advanced gastric cancer …
-
CLINICAL_TRIALS trial_result · 2023-09-18Clinical Trial Update: IGG Using in Laparoscopic Gastrectomy for Locally Advanced Gastric Cancer After Neoadjuvant Chemotherapy [Phase 3]
Phase 3 trial evaluating IGG in laparoscopic gastrectomy for locally advanced gastric cancer after neoadjuvant chemotherapy is active but no…
-
CLINICAL_TRIALS trial_result · 2023-09-11Clinical Trial Update: MAGNET (Magnetically Controlled Capsule for Assessment of Gastric Mucosa in Symptomatic Patients) [NA]
Clinical trial MAGNET evaluating magnetically controlled capsule for gastric mucosa assessment has completed with results posted; conditions…
-
CLINICAL_TRIALS trial_result · 2023-09-07Clinical Trial Update: Perioperative FLOT vs Adjuvant XELOX for CA Stomach [Phase 3]
Phase 3 trial updating perioperative FLOT vs adjuvant XELOX for stomach cancer is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2023-09-05Clinical Trial Update: CAPOX, Bevacizumab and Trastuzumab for Patients With HER2-Positive Metastatic Esophagogastric Cancer [Phase 2]
Phase 2 trial evaluating CAPOX chemotherapy plus Bevacizumab and Trastuzumab in HER2-positive metastatic esophagogastric cancer completed, w…
-
CLINICAL_TRIALS trial_result · 2023-08-30Clinical Trial Update: Efficacy and Safety of Fruquintinib With Sintilimab as First-line Therapy in Gastric Cancer [Phase 2]
Phase 2 trial evaluating fruquintinib with sintilimab as first-line therapy for stomach cancer.
-
CLINICAL_TRIALS trial_result · 2023-08-29Clinical Trial Update: Study of VE800 and Nivolumab in Patients With Selected Types of Advanced or Metastatic Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial of VE800 in combination with nivolumab has completed enrollment and posted results for selected advanced cancers. T…
-
CLINICAL_TRIALS trial_result · 2023-08-25Clinical Trial Update: Envollizumab Combined With Fruquintinib and SOX Versus SOX for Conversion Therapy in Advanced Gastric Cancer [Phase 3]
Phase 3 trial evaluating Envollizumab with Fruquintinib and SOX vs SOX for conversion therapy in advanced gastric cancer.
-
CLINICAL_TRIALS trial_result · 2023-08-18Clinical Trial Update: Clinical Efficacy of Trastuzumab in Combination With Capecitabine and Oxaliplatin for the Treatment of HER2-positive Advanced Gastric Cancer. [Phase 2]
Phase 2 clinical trial evaluating trastuzumab combined with capecitabine and oxaliplatin for HER2-positive advanced gastric cancer has compl…
-
CLINICAL_TRIALS trial_result · 2023-08-16Clinical Trial Update: Neoadjuvant Toripalimab for dMMR/MSI-H Gastric Cancer [Phase 2]
Phase 2 clinical trial updating neoadjuvant toripalimab in gastric/gastroesophageal junction adenocarcinoma with dMMR/MSI-H status.
-
CLINICAL_TRIALS trial_result · 2023-08-09Clinical Trial Update: Disitamab Vedotin, Fruquintinib and Tislelizumab in Second-line Treatment for HER2-positive MGC [Phase 1, Phase 2]
Early-phase trial update evaluating disitamab vedotin, fruquintinib, and tislelizumab as second-line therapy for HER2-positive gastric cance…
-
CLINICAL_TRIALS trial_result · 2023-08-08Clinical Trial Update: Sintilimab Combined With Modified FLOT Regimen in the Treatment of Metastatic Gastric Cancer [Phase 2]
Phase 2 trial updating the use of sintilimab with a modified FLOT regimen for metastatic gastric cancer.
-
CLINICAL_TRIALS trial_result · 2023-08-01Clinical Trial Update: Efficacy of Perioperative Chemotherapy Plus PD-1 Antibody in the Locally Advanced Gastric Cancer [Phase 2]
Phase 2 trial evaluating perioperative chemotherapy combined with a PD-1 antibody for locally advanced gastric cancer.
-
CLINICAL_TRIALS trial_result · 2023-07-17Clinical Trial Update: To Evaluate the Efficacy and Safety of Cadonilimab With SOX as Neoadjuvant Therapy for Resectable Locally Advanced Gastric or Gastroesophageal Junction Adenocarcinoma. [Phase 2]
Phase 2 clinical trial evaluating cadonilimab with SOX as neoadjuvant therapy for resectable locally advanced gastric or gastroesophageal ju…
-
CLINICAL_TRIALS trial_result · 2023-07-13Clinical Trial Update: A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101) [Phase 1, Phase 2]
Clinical trial update for KVA12123 as a standalone and in combination with pembrolizumab in advanced solid tumors; current status is unknown…
-
CLINICAL_TRIALS trial_result · 2023-07-12Clinical Trial Update: Continuation of Serplulimab Plus Chemotherapy After First Progression in Advanced Gastric or Gastro-oesophageal Junction Adenocarcinoma: an Open-label, Randomised Phase II Trial [Phase 2]
An open-label Phase 2 trial evaluating continuation of serplulimab plus chemotherapy after first progression in advanced gastric or gastro-e…